176 related articles for article (PubMed ID: 24211628)
1. Survival analysis of acquired immune deficiency syndrome patients with and without hepatitis C virus infection at a reference center for sexually transmitted diseases/acquired immune deficiency syndrome in São Paulo, Brazil.
Alencar WK; Duarte PS; Waldman EA
Braz J Infect Dis; 2014; 18(2):150-7. PubMed ID: 24211628
[TBL] [Abstract][Full Text] [Related]
2. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.
Berenguer J; Rodríguez-Castellano E; Carrero A; Von Wichmann MA; Montero M; Galindo MJ; Mallolas J; Crespo M; Téllez MJ; Quereda C; Sanz J; Barros C; Tural C; Santos I; Pulido F; Guardiola JM; Rubio R; Ortega E; Montes ML; Jusdado JJ; Gaspar G; Esteban H; Bellón JM; González-García J;
Hepatology; 2017 Aug; 66(2):344-356. PubMed ID: 28109003
[TBL] [Abstract][Full Text] [Related]
3. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
4. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
[TBL] [Abstract][Full Text] [Related]
5. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
[TBL] [Abstract][Full Text] [Related]
6. Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
Sarkar M; Bacchetti P; French AL; Tien P; Glesby MJ; Nowicki M; Plankey M; Gange S; Sharp G; Minkoff H; Peters MG;
Hepatology; 2012 Nov; 56(5):1699-705. PubMed ID: 22618868
[TBL] [Abstract][Full Text] [Related]
7. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.
Jain MK; Seremba E; Bhore R; Dao D; Joshi R; Attar N; Yuan HJ; Lee WM
AIDS Patient Care STDS; 2012 Feb; 26(2):73-80. PubMed ID: 22239101
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
[TBL] [Abstract][Full Text] [Related]
9. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.
Tedaldi E; Peters L; Neuhaus J; Puoti M; Rockstroh J; Klein MB; Dore GJ; Mocroft A; Soriano V; Clotet B; Lundgren JD;
Clin Infect Dis; 2008 Dec; 47(11):1468-75. PubMed ID: 18959492
[TBL] [Abstract][Full Text] [Related]
11. [Research on the causes of death associated with combined effects of HBV and HCV infection in patients with acquired immunodeficiency syndrome].
Guo PL; Cai WP; Chen XJ; He HL; Hu FY; Tang XP; Li LH
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):495-498. PubMed ID: 30317770
[No Abstract] [Full Text] [Related]
12. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.
Weis N; Lindhardt BO; Kronborg G; Hansen AB; Laursen AL; Christensen PB; Nielsen H; Moller A; Sorensen HT; Obel N
Clin Infect Dis; 2006 May; 42(10):1481-7. PubMed ID: 16619163
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study.
; Peters L; Neuhaus J; Mocroft A; Soriano V; Rockstroh J; Dore G; Puoti M; Tedaldi E; Clotet B; Kupfer B; Lundgren JD; Klein MB
Antivir Ther; 2011; 16(5):667-75. PubMed ID: 21817188
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.
Anderson KB; Guest JL; Rimland D
Clin Infect Dis; 2004 Nov; 39(10):1507-13. PubMed ID: 15546088
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus.
Diamondstone LS; Blakley SA; Rice JC; Clark RA; Goedert JJ
Am J Epidemiol; 1995 Aug; 142(3):304-13. PubMed ID: 7631634
[TBL] [Abstract][Full Text] [Related]
17. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy.
Branch AD; Van Natta ML; Vachon ML; Dieterich DT; Meinert CL; Jabs DA;
Clin Infect Dis; 2012 Jul; 55(1):137-44. PubMed ID: 22534149
[TBL] [Abstract][Full Text] [Related]
18. HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.
Nikolopoulos GK; Paraskevis D; Psichogiou M; Hatzakis A
J Med Virol; 2016 Mar; 88(3):466-73. PubMed ID: 26288334
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.
Rockstroh JK; Spengler U; Sudhop T; Ewig S; Theisen A; Hammerstein U; Bierhoff E; Fischer HP; Oldenburg J; Brackmann HH; Sauerbruch T
Am J Gastroenterol; 1996 Dec; 91(12):2563-8. PubMed ID: 8946987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
